Avalyn Pharma Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Avalyn Pharma Inc. has filed 53 SEC EDGAR filings since 16 Nov 2012

SEC filing history

Showing 1-25 of 53 matching filings.

Per page
25
Current page
1
SCHEDULE 13D File 005-95651

SCHEDULE 13D filing

Filing date
08 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D File 005-95651

SCHEDULE 13D filing

Filing date
08 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-95651

SCHEDULE 13G filing

Filing date
07 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 May 2026
Reporting date
01 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-95651

SCHEDULE 13G filing

Filing date
05 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 May 2026
Reporting date
01 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 May 2026
Reporting date
29 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
01 May 2026
Reporting date
01 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
01 May 2026
Reporting date
01 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
01 May 2026
Reporting date
29 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
01 May 2026
Reporting date
29 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
01 May 2026
Reporting date
29 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
01 May 2026
Reporting date
29 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
01 May 2026
Reporting date
29 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
01 May 2026
Reporting date
01 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
01 May 2026
Reporting date
29 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
01 May 2026
Reporting date
29 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
01 May 2026
Reporting date
29 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-294932

424B4

Filing date
30 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-294932

EFFECT filing

Filing date
29 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
29 Apr 2026
Reporting date
29 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .